Lapatinib

Rating: Category: Others

AASraw is with synthesis and production ability from gram to mass order of Lapatinib (CAS 231277-92-2), under CGMP regulation and trackable quality control system.

Lapatinib powder is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.

Product Description

Lapatinib video

I.Lapatinib basic Characters:

Name:	Lapatinib
CAS:	231277-92-2
Molecular Formula:	C29H26ClFN4O4S
Molecular Weight:	581.0575432
Melt Point:	137-139° C
Storage Temp:	4° C
Color:	White crystalline powder

II. Lapatinib (231277-92-2) usage in steroids cycle

1. Names:

Lapatinib (CAS 231277-92-2), trade name is Tykerb, Tyver.

2. Lapatinib Usage:

1) Lapitinib is a tablet to be taken by mouth.
2) Tablets come in 1 dosage size, 250mg.
3) Take lapitinib exactly as instructed by your doctor.
4) Lapitinib should be taken at least one hour before, or at least one hour after food (take total dose at the same time daily, dividing doses is not recommended).
5) Do not eat or drink grapefruit products while taking Lapatinib (231277-92-2).
6) If you miss a dose of lapitinib, take it as soon as you remember that day. If you miss a day, do not double your dose the next day. Just skip the missed dose.Call your healthcare provider if you are not sure what to do.
7) Your doctor may adjust your dose of lapatinib depending on how you tolerate the treatment.

3. Warning on Lapatinib

Lapatinib may cause liver damage which can be severe or life-threatening. Liver damage can occur as soon as several days or as late as several months after the start of treatment with Lapatinib (CAS 231277-92-2). Tell your doctor if you have or have ever had liver disease. If you experience any of the following symptoms, call your doctor immediately: itching, yellowing of the skin or eyes, dark urine, pain in the upper right part of the stomach, unusual bleeding or bruising, or pale or dark stools.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain laboratory tests before and during your treatment to see whether your liver islikely to be damaged or has been damaged by lapatinib.

Talk to your doctor about the risks of taking lapatinib.

4.Further instructions:

Lapatinib is a type of targeted cancer drug (biological therapy) called a protein kinase inhibitor (TKI). It is a targeted treatment used for cancers that have large amounts of a protein called HER2 (human epidermal growth factor receptor 2).

Some breast cancers have large amounts of HER2. They are called HER2 positivecancers. HER2 makes the cancer cells grow and divide. Lapatinib (231277-92-2) switches off HER2 to make the cells stop growing or die.

III. Lapatinib (231277-92-2) HCML

IV. How to buy Lapatinib from AASraw?

1.To contact us by our email inquiry system,or online skypecustomer service representative(CSR).
2.To provide us your inquired quantity and address.
3.Our CSR will provide you the quotation, payment term, tracking number, delivery ways and estimated arrival date(ETA).
4.Payment done and the goods will be sent out in 12 hours(For order within 10kg).
5.Goods received and give comments.